Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23704713 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Intact Vagal Innervation for and Glucagon-like Peptide-1 (GLP-1) Effects
Condition: Vagotomy, Truncal
Interventions: Drug: Dipeptidyl peptidase 4 (DPP 4) inhibitor;   Other: oral glucose

Indicates status has not been verified in more than two years